1. ReportLinker Data
  2. Life Sciences
  3. Pharmaceutical
  4. Pharmaceutical Exports
  5. Export of Adrenal Cortic…

Export of adrenal cortical hormones from Hungary drops in 2016

According to refreshed numbers presented by United Nations Statistical Office, the indicator decreased by 7.75 percent compared to the previous year. Pharmaceutical export declined by 11 206 592 US Dollar, as it follows the tendency of the prior year when it fell by 2.64 percent. Hungary saw a growth of 1 134.53% in pharmaceutical export over the past 25 years. As well as it has shown a 0.01% compound average annual growth rate over the five years with a marginal overall rise since the start of time series. It averaged 46 338 585.92 US Dollar from 1992 to 2016 and it attained its all-time high of 148 578 496 US Dollar in 2014 and record low of 9 548 000 US Dollar in 1995.

Export of adrenal cortical hormones from Hungary drops in 2016
Date US Dollar Variation
2016 133 452 816.00 -7.75
2015 144 659 408.00 -2.64
2014 148 578 496.00 12.7
2013 131 835 784.00 3.66
2012 127 178 144.00 -0.52
2011 127 845 000.00 73.62
2010 73 636 000.00 185.5
2009 25 792 000.00 -25.04
2008 34 408 000.00 60.67
2007 21 415 000.00 14.54

Related Statistics

Pharmaceutical Exports in other Countries

Main Pharmaceutical Indicators

  • Pharmaceutical Imports

  • Pharmaceutical Exports

  • Medicine Use

    Use of medicines, usually meadured in in defined daily dosis (DDD) per day. The DDD consists of the assumed average maintenance dose per day for a drug used for its main indication in adults. Based on: World Health Organization.

  • Pharmaceutical Production

    Manufacture of basic pharmaceutical products and pharmaceutical preparations in million units of national currency or in volume index of production.

  • Pharmacist Density

  • Spending On Medicines

    Measures total value of spending on prescription medicines and insulins by retail pharmacies, hospitals, and other institutional pharmacies at invoice prices.

  • Re-Imbursed Pharmaceutical

    Share of re-imbursed medication in the pharmaceutical market, usually expressed in percentage of medication sales or in value of reimbursements (thousands or millions of national currency). It can be measured separately for generic medication and brand-name medication, or for the whole market. Based on: Organisation for Economic Co-operation and Development.

  • Pharmaceutical Registrations

  • Pharmaceutical Revenue

    Revenue of pharmaceutical industry. The latter is comprised of companies engaged in researching, developing, manufacturing and distributing drugs for human or veterinary use. Based on: United States Department of Commerce.

  • Drug Store Retail Sales